Filing Details

Accession Number:
0000899243-20-003818
Form Type:
5
Zero Holdings:
No
Publication Time:
2020-02-10 16:20:28
Reporting Period:
2019-12-31
Accepted Time:
2020-02-10 16:20:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1042418 Inhibitor Therapeutics Inc. INTI Services-Commercial Physical & Biological Research (8731) 541641133
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612372 Mark W. Watson C/O Inhibitor Therapeutics, Inc.
4830 W. Kennedy Blvd., Suite 600
Tampa FL 33609
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-12 500 $0.06 1,054,100 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct